Bilimsel çalışmalar

Prof. Dr. Tayfur Toptaş

163 yayın. Her yayının yanında bilginin kaynağı yazar.

Profile dön

  1. Real-World Outcomes of Belinostat in Relapsed Refractory T-Cell Lymphomas: A Report from the Lymphoma Study Group of Turkish Society of Hematology

    Journal of Clinical Medicine, 2026

    DOI 10.3390/jcm15166350 PMID 42652754 Açık erişimli tam metinKaynak: OpenAlex

  2. Lymphoproliferative Presentation of DIAL Syndrome Due to a Recurrent DIAPH1 p.Arg351* Variant: A Case Report

    Molecular Syndromology, 2026

    DOI 10.1159/msy/adrag001 Kaynak: OpenAlex

  3. HIV-associated lymphoproliferative disorders: Single-center experience

    Medicine, 2026

    DOI 10.1097/md.0000000000047992 PMID 41790642 Açık erişimli tam metinKaynak: OpenAlex

  4. Infection incidence, timing, and predictors in newly diagnosed multiple myeloma: a real-world retrospective cohort study

    Frontiers in Medicine, 2026

    DOI 10.3389/fmed.2026.1829429 PMID 42221100 Açık erişimli tam metinKaynak: OpenAlex

  5. Pretransplant Small-airway Dysfunction is Associated with Posttransplant Complications in Adult HSCT Recipients

    Thoracic research and practice, 2026

    DOI 10.4274/thoracrespract.2026.2026-5-9 PMID 42840756 Açık erişimli tam metinKaynak: Europe PMC

  6. Frequency and Potential Disease-Modifying Role of MEFV Variants in Acute Myeloid Leukemia and Myelodysplastic Syndrome: A Retrospective Case–Control Study

    Medicina, 2026

    DOI 10.3390/medicina62112093 Açık erişimli tam metinKaynak: ORCID

  7. Iron‐Related Biomarkers and Red Cell Indices as Predictors of PBSC Collection Outcomes in Healthy Allogeneic Donors

    Journal of Clinical Apheresis, 2026

    DOI 10.1002/jca.70189 PMID 42830546 Açık erişimli tam metinKaynak: ORCID

  8. Intensive Versus Non-Intensive Therapy in Older Patients with Acute Myeloid Leukemia: A Real-World Experience

    Medicina, 2026

    DOI 10.3390/medicina62091733 PMID 42796339 Açık erişimli tam metinKaynak: ORCID

  9. Real world data of carfilzomib once weekly dosing in patients with relapsed and refractory multiple myeloma: a retrospective single center experience

    Journal of Current Hematology & Oncology Research, 2026

    DOI 10.51271/jchor-0091 Açık erişimli tam metinKaynak: ORCID

  10. Prognostic Impact of Extranodal Organ Burden in Classical Hodgkin Lymphoma with Extranodal Involvement: A Retrospective Cohort Analysis

    Journal of Clinical Medicine, 2026

    DOI 10.3390/jcm15156067 PMID 42590169 Açık erişimli tam metinKaynak: ORCID

  11. Real-World Treatment Patterns and Safety Outcomes of Targeted Therapies in a Single-Center Chronic Lymphocytic Leukemia Cohort

    Medicina, 2026

    DOI 10.3390/medicina62040736 PMID 42075610 Açık erişimli tam metinKaynak: ORCID

  12. RNA sequencing detects more challenging cases of somatic hypermutation in the <i>IgHV</i> gene in patients with chronic lymphocytic leukemia

    Turkish journal of medical sciences, 2026

    DOI 10.55730/1300-0144.6357 PMID 42677266 Açık erişimli tam metinKaynak: Europe PMC

  13. Polycythemia Vera in Clinical Practice: A Single-Center Experience Focusing on Thrombotic Complications and Management Strategies

    Indian Journal of Hematology and Blood Transfusion, 2026

    DOI 10.1007/s12288-026-02400-z Kaynak: OpenAlex

  14. Uncovering the Clinical Factors Determining the Survival of Multiple Myeloma Patients with Extramedullary Disease: Insights from a Single-Centre Study

    Indian Journal of Hematology and Blood Transfusion, 2026

    DOI 10.1007/s12288-026-02419-2 Kaynak: OpenAlex

  15. Comparative Evaluation of Single-Dose and Split-Dose Melphalan Conditioning Concerning Toxicity Profiles and Engraftment Kinetics: A Propensity Score-Matched Analysis

    Transplantation and Cellular Therapy, 2026

    DOI 10.1016/j.jtct.2026.05.044 PMID 42219059 Kaynak: OpenAlex

  16. Concurrent Langerhans Cell Histiocytosis and KMT2A-Rearranged Acute Myeloid Leukemia Showing Dual Response to Azacitidine

    Current Genetic Medicine Reports, 2026

    DOI 10.1007/s40142-026-00249-2 Kaynak: OpenAlex

  17. Immune Thrombocytopenic Purpura: Late-Onset Thrombocytopenia Following Mild COVID-19 Infection

    Cureus, 2026

    DOI 10.7759/cureus.113527 PMID 42662966 Açık erişimli tam metinKaynak: OpenAlex

  18. Bone Marrow Fibrosis Is Associated with Inferior Survival in Lower-Risk Myelodysplastic Syndromes and Adds Prognostic Information to IPSS-R and IPSS-M

    Clinical Lymphoma Myeloma & Leukemia, 2026

    DOI 10.1016/j.clml.2026.10.018 Kaynak: OpenAlex

  19. Real-World Outcomes of Antifungal Prophylaxis in Adult Acute Lymphoblastic Leukemia Patients: A Multicenter Comparison of the Use of Fluconazole and Micafungin

    Journal of Clinical Medicine, 2025

    DOI 10.3390/jcm14207294 PMID 41156164 Açık erişimli tam metinKaynak: OpenAlex

  20. Real-Life Retrospective Turkiye Data of the De-Escalation of ABVD to AVD in Hodgkin Lymphoma: On Behalf of the TSH Turkish Lymphoma Study Group

    Journal of Clinical Medicine, 2025

    DOI 10.3390/jcm14196813 PMID 41095893 Açık erişimli tam metinKaynak: OpenAlex

  21. ABCL-480: HIV-Associated Lymphoproliferative Disorders: Single-Center Experience

    Clinical Lymphoma Myeloma & Leukemia, 2025

    DOI 10.1016/s2152-2650(25)02263-3 Kaynak: OpenAlex

  22. POSTER: ABCL-480 HIV-Associated Lymphoproliferative Disorders: Single-Center Experience

    Clinical Lymphoma Myeloma & Leukemia, 2025

    DOI 10.1016/s2152-2650(25)00997-8 Kaynak: OpenAlex

  23. Second-line use of dasatinib and nilotinib in a real-world patient population with chronic phase chronic myeloid leukemia

    Hematology, 2025

    DOI 10.1080/16078454.2025.2478344 PMID 40098089 3 atıf (Europe PMC) Açık erişimli tam metinKaynak: ORCID

  24. Determinants of Eligibility and Timing of Autologous Transplantation in Multiple Myeloma: The Role of R-MCI and Diagnostic Plasma Cell Burden

    Diagnostics, 2025

    DOI 10.3390/diagnostics15233038 PMID 41374419 1 atıf (Europe PMC) Açık erişimli tam metinKaynak: ORCID

  25. Determinants of Eligibility and Timing of Autologous Transplantation in Multiple Myeloma: The Role of R-MCI and Diagnostic Plasma Cell Burden

    2025

    DOI 10.20944/preprints202511.0307.v1 Açık erişimli tam metinKaynak: ORCID

  26. Novel GLA mutation in a high-consanguinity region: insights from Fabry disease screening in Turkiye

    Journal of Health Sciences and Medicine, 2025

    DOI 10.32322/jhsm.1759818 1 atıf (OpenAlex) Açık erişimli tam metinKaynak: ORCID

  27. Characteristics of patients with diffuse large B-cell lymphoma of gastrointestinal tract: A single center experience

    Marmara Medical Journal, 2025

    DOI 10.5472/marumj.1799981 Açık erişimli tam metinKaynak: ORCID

  28. The Impact of Surface CD20 Expression and Soluble CD20 Levels on In Vivo Cell Fragility in Chronic Lymphocytic Leukemia

    Journal of Clinical Medicine, 2025

    DOI 10.3390/jcm14217529 PMID 41226926 Açık erişimli tam metinKaynak: ORCID

  29. The Impact of Surface CD20 Expression and Soluble CD20 Levels on In Vivo Cell Fragility in Chronic Lymphocytic Leukemia

    2025

    DOI 10.20944/preprints202509.1766.v1 Açık erişimli tam metinKaynak: ORCID

  30. A Large Room for Improvement in the Management of Relapsed/Refractory Large B-Cell Lymphoma in Türkiye: Real-World Outcomes in a Setting Without Access to T-Cell Redirecting Therapies

    Turkish journal of haematology : official journal of Turkish Society of Haematology, 2025

    DOI 10.4274/tjh.galenos.2025.2025.0352 PMID 41199540 1 atıf (Europe PMC) Açık erişimli tam metinKaynak: Europe PMC

  31. Anti-T lymphocyte globulin plus posttransplant cyclophosphamide 25 mg/kg versus posttransplant cyclophosphamide 50 mg/kg in patients with acute leukemias

    Bone Marrow Transplantation, 2025

    DOI 10.1038/s41409-025-02564-8 PMID 40223010 3 atıf (OpenAlex) Açık erişimli tam metinKaynak: OpenAlex

  32. Acute lymphoblastic leukemia following lenalidomide therapy in multiple myeloma patients: Two case reports and review of the literature

    Current Problems in Cancer, 2025

    DOI 10.1016/j.currproblcancer.2025.101219 PMID 40373458 2 atıf (OpenAlex) Kaynak: OpenAlex

  33. The Impact of a Major Earthquake on Nutritional Status and Survival in Hemodialysis Patients: A Retrospective Observational Study

    Journal of Renal Nutrition, 2025

    DOI 10.1053/j.jrn.2025.09.005 PMID 41352749 1 atıf (OpenAlex) Kaynak: OpenAlex

  34. Exploring an independent association between rituximab‐cyclophosphamide‐doxorubicin‐vincristine‐prednisolone dose intensity and clinical outcomes in large B‐cell lymphoma: Analyses of subsequent endpoints following a complete response in a real‐world cohort of 1369 patients

    Cancer, 2025

    DOI 10.1002/cncr.70248 PMID 41468167 1 atıf (OpenAlex) Açık erişimli tam metinKaynak: OpenAlex

  35. Simplified Molecular International Prognostic Index as an eligibility criterion for clinical trials: Analysis of the Turkish Lymphoma Study Group's large B‐cell lymphoma cohort

    British Journal of Haematology, 2025

    DOI 10.1111/bjh.20111 PMID 40524448 1 atıf (OpenAlex) Açık erişimli tam metinKaynak: OpenAlex

  36. ABCL-283: A Case of Multiple Serial Treatment-Resistant Primary Mediastinal B-Cell Lymphoma With Near-Complete Response to Nivolumab Plus Brentuxumab Vedotin

    Clinical Lymphoma Myeloma & Leukemia, 2025

    DOI 10.1016/s2152-2650(25)02242-6 1 atıf (OpenAlex) Kaynak: OpenAlex

  37. Bortezomib-Based Salvage Followed by Autologous Transplantation in a Patient with HIV-Negative Plasmablastic Lymphoma

    Indian Journal of Hematology and Blood Transfusion, 2025

    DOI 10.1007/s12288-025-01960-w PMID 41522536 Açık erişimli tam metinKaynak: OpenAlex

  38. 664 | SIMPLIFIED MOLECULAR IPI AS ELIGIBILITY CRITERIA FOR CLINICAL TRIALS: ANALYSIS OF THE TURKISH LYMPHOMA STUDY GROUP’S LARGE B‐CELL LYMPHOMA COHORT

    Hematological Oncology, 2025

    DOI 10.1002/hon.70096_664 Açık erişimli tam metinKaynak: OpenAlex

  39. VEXAS syndrome — new kid in town

    Acta Haematologica Polonica, 2025

    DOI 10.5603/ahp.105300 Açık erişimli tam metinKaynak: OpenAlex

  40. 1305eP Frequency of MEFV gene mutations associated with familial mediterranean fever in multiple myeloma and other plasma cell neoplasms and their effects on clinical course of the disease

    Annals of Oncology, 2025

    DOI 10.1016/j.annonc.2025.08.1939 Açık erişimli tam metinKaynak: OpenAlex

  41. Immunological biomarkers and TARC/CCL17 in myelodysplastic syndrome: Insights into immune microenvironment regulation

    Blood, 2025

    DOI 10.1182/blood-2025-7359 Açık erişimli tam metinKaynak: OpenAlex

  42. Peripheral blood dendritic cell subtype alterations in polycythemia vera: Clinical correlations with disease risk and inflammatory profile

    Blood, 2025

    DOI 10.1182/blood-2025-1989 Açık erişimli tam metinKaynak: OpenAlex

  43. Nüks Etmiş veya Dirençli Büyük B-Hücreli Lenfomanın Tedavisinde Karşılanmamış İhtiyaçlar: Bispesifik ve CAR-T Erişimi Olmayan Çok Merkezli 1369 Hasta Kohortunda İkinci Sıra Tedavilerinin İncelenmesi

    Kocaeli Üniversitesi - AVESİS, 2025

    Kaynak: OpenAlex

  44. Survival Outcomes of Patients with Primary Plasma Cell Leukemia in the Era of Proteasome Inhibitors and Immunomodulatory Agents: A Real-Life Multicenter Analysis

    Turkish Journal of Hematology, 2024

    DOI 10.4274/tjh.galenos.2024.2023.0450 PMID 39501735 2 atıf (Europe PMC) Açık erişimli tam metinKaynak: OpenAlex

  45. A new scoring system to predict survival in elderly advanced stage Hodgkin lymphoma patients

    Leukemia and Lymphoma, 2024

    DOI 10.1080/10428194.2024.2395458 PMID 39269267 5 atıf (Europe PMC) Açık erişimli tam metinKaynak: ORCID

  46. Management of Adult Primary Immune Thrombocytopenia: DelphiBased Consensus Recommendations

    The Turkish Journal of Hematology, 2024

    DOI 10.4274/tjh.galenos.2024.2024.0055 PMID 38545671 2 atıf (Europe PMC) Açık erişimli tam metinKaynak: ORCID

  47. Management of Primary Immune Thrombocytopenia: Turkish Modified Delphi-Based Consensus Statement for Special Considerations

    The Turkish Journal of Hematology, 2024

    DOI 10.4274/tjh.galenos.2024.2024.0101 PMID 38801066 2 atıf (Europe PMC) Açık erişimli tam metinKaynak: ORCID

  48. There is no association between serum endotoxin levels and inflammation in asthma

    Journal of Asthma, 2024

    DOI 10.1080/02770903.2024.2311233 PMID 38289083 1 atıf (Europe PMC) Kaynak: ORCID

  49. The Diagnostic Value of Abnormal Bone Marrow Signal Changes on Magnetic Resonance Imaging: Is Bone Marrow Biopsy Essential?

    Current Medical Imaging Formerly Current Medical Imaging Reviews, 2024

    DOI 10.2174/0115734056267087231228124325 PMID 38454769 1 atıf (OpenAlex) Açık erişimli tam metinKaynak: OpenAlex

  50. MEDIASTINAL GRAY ZONE LYMPHOMA; SHADES OF GRAY

    Hematology Transfusion and Cell Therapy, 2024

    DOI 10.1016/j.htct.2024.04.031 1 atıf (OpenAlex) Açık erişimli tam metinKaynak: OpenAlex